retatrutide trials weight loss (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Retatrutide Promises Big Weight Loss,

Fighting a digital hydra The Pharmaceutical Task Group , an industry body representing organised pharmacy and manufacturing interests, views this underground trade as a direct violation of the laws protecting the South African public

Some common side effects of GLP-1 medications include: Nausea and vomiting Diarrhea Constipation Abdominal pain Loss of appetite Headaches Infection Irritation at the injection site Patients on GLP-1 therapies can also experience muscle loss or bone density loss with prolonged use, which can compound some of the natural physical changes that accompany menopause

"Five months in, I didn't even want my husband to come near me," Souza said

Use the supplier page for trust checks, documentation, reviews, and contact routes

The regulatory landscape and what it means for dosing The availability and dosage charts of these compounds are tied to their regulatory status, and that status affects everything from access to quality to clinical support

With insurance coverage (where available), copays can range from $25 to several hundred dollars depending on the plan